Search research articles
Contact Us
Filters
Showing results (361-370 of 423) with videos related to
Page
of 43
Sort By:
Journal of Cancer Research and Clinical Oncology
|
April 14, 2010
Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease
Yu-Chung Huang, Jen-Kou Lin, Wei-Shone Chen, et al.
Hepato-Gastroenterology
|
September 24, 2011
The efficacy of chemotherapy in patients with high-grade metastatic colon cancer
Chia-Jen Liu, Jen-Kou Lin, Wei-Shone Chen, et al.
Hepatology (Baltimore, Md.)
|
January 21, 2022
Innate-like bystander-activated CD38<sup>+</sup> HLA-DR<sup>+</sup> CD8<sup>+</sup> T cells play a pathogenic role in patients with chronic hepatitis C
Chien-Hao Huang, Jian-He Fan, Wen-Juei Jeng, et al.
Frontiers in Oncology
|
May 3, 2021
Significance of Kynurenine 3-Monooxygenase Expression in Colorectal Cancer
Chun-Yu Liu, Tzu-Ting Huang, Ji-Lin Chen, et al.
International Journal of Molecular Sciences
|
July 2, 2021
Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal Cancer
Hung-Ming Chen, Chun-Chi Lin, Wei-Shone Chen, et al.
British Journal of Cancer
|
June 30, 2021
The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon
Kun-Han Lee, Wei-Shone Chen, Jeng-Kai Jiang, et al.
Journal of Clinical and Translational Hepatology
|
March 11, 2026
Prognostic Nutritional Index Predicts Outcomes in Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab: A Propensity Score-matched Analysis
Yuan-Hung Kuo, Wei Teng, Yen-Hao Chen, et al.
American Journal of Clinical Oncology
|
November 7, 2019
Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal Cancer
Cheng-Chun Tai, Wei-Shone Chen, Jeng-Kai Jiang, et al.
American Journal of Hematology
|
August 25, 2010
High early mortality rate in elderly patients with multiple myeloma receiving a vincristine-doxorubicin-dexamethasone regimen
Hao-Wei Teng, Chung-Jen Teng, Wei-Shu Wang, et al.
Journal of Medical Virology
|
December 18, 2023
Antiviral therapy reduces hepatocellular carcinoma through suppressing hepatitis B virus replication may improve ER stress, mitochondrial and metabolic dysfunctions and decrease p62 in hybridized mice with single HBV transgene and miR-122
Yuh-Jin Liang, Yu-Wei Chiou, Abby Pei-Ting Chiu, et al.
Page
of 43
Search research articles
Search
Showing results (361-370 of 423) with videos related to
Sort By:
Page
of 43
Journal of Cancer Research and Clinical Oncology
|
April 14, 2010
Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease
Yu-Chung Huang, Jen-Kou Lin, Wei-Shone Chen, et al.
Hepato-Gastroenterology
|
September 24, 2011
The efficacy of chemotherapy in patients with high-grade metastatic colon cancer
Chia-Jen Liu, Jen-Kou Lin, Wei-Shone Chen, et al.
Hepatology (Baltimore, Md.)
|
January 21, 2022
Innate-like bystander-activated CD38<sup>+</sup> HLA-DR<sup>+</sup> CD8<sup>+</sup> T cells play a pathogenic role in patients with chronic hepatitis C
Chien-Hao Huang, Jian-He Fan, Wen-Juei Jeng, et al.
Frontiers in Oncology
|
May 3, 2021
Significance of Kynurenine 3-Monooxygenase Expression in Colorectal Cancer
Chun-Yu Liu, Tzu-Ting Huang, Ji-Lin Chen, et al.
International Journal of Molecular Sciences
|
July 2, 2021
Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal Cancer
Hung-Ming Chen, Chun-Chi Lin, Wei-Shone Chen, et al.
British Journal of Cancer
|
June 30, 2021
The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon
Kun-Han Lee, Wei-Shone Chen, Jeng-Kai Jiang, et al.
Journal of Clinical and Translational Hepatology
|
March 11, 2026
Prognostic Nutritional Index Predicts Outcomes in Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab: A Propensity Score-matched Analysis
Yuan-Hung Kuo, Wei Teng, Yen-Hao Chen, et al.
American Journal of Clinical Oncology
|
November 7, 2019
Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal Cancer
Cheng-Chun Tai, Wei-Shone Chen, Jeng-Kai Jiang, et al.
American Journal of Hematology
|
August 25, 2010
High early mortality rate in elderly patients with multiple myeloma receiving a vincristine-doxorubicin-dexamethasone regimen
Hao-Wei Teng, Chung-Jen Teng, Wei-Shu Wang, et al.
Journal of Medical Virology
|
December 18, 2023
Antiviral therapy reduces hepatocellular carcinoma through suppressing hepatitis B virus replication may improve ER stress, mitochondrial and metabolic dysfunctions and decrease p62 in hybridized mice with single HBV transgene and miR-122
Yuh-Jin Liang, Yu-Wei Chiou, Abby Pei-Ting Chiu, et al.
Page
of 43